New diabetes clinical trial: GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
Published on: 2026-07-31T04:00:00Z Conditions : Breast Cancer (Locally Advanced or Metastatic) Interventions : Drug: GB268; Drug: Nab-Paclitaxel; Drug: Datopotamab Deruxtecan (Dato-DXd); Drug: Sacituzumab Tirumotecan Sponsors : Eddingpharm (Zhuhai) Co., Ltd. Not yet recruiting https://ift.tt/Lgp6kGn